VYGR Operating Cash Flow Growth
Voyager Therapeutics Inc · Operating Cash Flow Growth
VYGR Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-6.09%period ending
VYGR TTM Cash from Operations YoY % (446.53% → -6.09%)
Year-over-year change
High-resolution chart · PNG
VYGR operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -6.0878% | |
| -14.3063% | |
| -765.2319% | |
| -375.6652% | |
| -544.8763% | |
| -953.3801% | |
| -119.6486% | |
| -127.44% | |
| -118.6933% | |
| -82.8775% | |
| 722.9035% | |
| 718.2525% | |
| 1,366.9364% | |
| 3,391.1162% | |
| 76.6296% | |
| 112.6071% | |
| 107.0838% | |
| 102.4604% | |
| 44.6576% | |
| 11.623% | |
| 4.4345% | |
| 15.2734% | |
| -298.7342% | |
| -305.7532% | |
| -283.9527% | |
| -273.5663% | |
| 406.3259% | |
| 848.1249% | |
| 1,218.7947% | |
| 3,803.7967% | |
| 74.1043% | |
| 89.3085% | |
| 91.4431% | |
| 103.2862% | |
| -44.4141% | |
| -53.049% | |
| -51.8249% | |
| -44.2794% | |
| -202.8645% | |
| -184.5498% | |
| -170.3338% | |
| -159.3725% | |
| 446.5263% |